INS and type 2 diabetes mellitus: Insulin and glucagon can activate the transport of glycogen kinase by glucose transporters, modifying the amount of glycogen kinase in the cytoplasm of hepatocytes and managing the intracellular glucose content for the management of type 2 diabetes.